Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change

Core Viewpoint - Amarin Corporation is implementing a Ratio Change for its American Depositary Shares (ADS) to comply with Nasdaq's minimum bid price requirement, changing the ratio from 1 ADS representing 1 ordinary share to 1 ADS representing 20 ordinary shares, effective April 11, 2025 [1][2]. Group 1: Ratio Change Details - The Ratio Change aims to increase the per share market price of the Company's ADSs to meet Nasdaq's $1.00 minimum bid price requirement [2]. - The Company cannot guarantee that the trading price per ADS after the Ratio Change will be equal to or greater than twenty times the trading price per ADS before the Ratio Change [2]. Group 2: Impact on Ordinary Shares - The ordinary shares of Amarin Corporation will remain unaffected by the Ratio Change, and the ADSs will continue to trade on The Nasdaq Capital Market under the symbol "AMRN" [3]. Group 3: Company Overview - Amarin is an innovative pharmaceutical company focused on cardiovascular disease management, aiming to enhance the scientific understanding of cardiovascular risk beyond traditional therapies [3]. - The Company has offices in Bridgewater, New Jersey, Dublin, Ireland, Zug in Switzerland, and other European countries, along with commercial partners and suppliers globally [3].